Functional assessment of pharmacological telomerase activators in human T cells

Cells

Volumn 2, Issue 1, 2013, Pages 57-63

  Molgora, Brenda ^a   Bateman, Riley ^a   Sweeney, Greg ^a   Finger, Danielle ^a   Dimler, Taylor ^a   Effros, Rita B ^b   Valenzuela, Hector F ^a  

^a WHITTIER COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cellular senescence; TA 65; Telomerase activators

Indexed keywords

ASTRAGALUS MEMBRANACEUS EXTRACT; CD3 ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; HTA; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY CD28; PROTEIN KINASE B INHIBITOR; TA 65; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELL PROLIFERATION; CELL STIMULATION; FUNCTIONAL ASSESSMENT; GROWTH DISORDER; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84964507039     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells2010057     Document Type: Article

References (23)

1. de Lange, T. Shelterin: The protein complex that shapes and safeguards human telomeres. Gene Dev. 2005, 19, 2100-2110.
2. Artandi, S.E.; DePinho, R.A. Telomeres and telomerase in cancer. Carcinogenesis 2010, 31, 9-18.
3. Counter, C.M.; Avilion, A.A.; LeFeuvre, C.E.; Stewart, N.G.; Greider, C.W.; Harley, C.B.; Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in inmortal cells which express telomerase activity. EMBO J. 1992, 11, 1921-1929.
4. Price, C. M., Centromeres and telomeres. Curr Opin Cell Biol 1992, 4, 379-84.
5. Monteiro, J.; Batliwalla, F.; Ostrer, H.; Gregersen, P.K. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 1996, 156, 3587-3590.
6. Roth, A.; Yssel, H.; Pene, J.; Chavez, E.A.; Schertzer, M.; Lansdorp, P.M.; Spits, H.; Luiten, R.M. Telomerase levels control the lifespan of human T lymphocytes. Blood 2003, 102, 849-857.
7. Weng, N.P.; Levine, B.L.; June, C.H.; Hodes, R.J. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA 1995, 92, 11091-11094.
8. Valenzuela, H.F.; Effros, R.B. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin. Immunol. 2002, 105, 117-125.
9. Hiyama, K.; Hirai, Y.; Kyoizumi, S.; Akiyama, M.; Hiyama, E.; Piatyszek, M.A.; Shay, J.W.; Ishioka, S.; Yamakido, M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 1995, 155, 3711-3715.
10. Jaskelioff, M.; Muller, F.L.; Paik, J.H.; Thomas, E.; Jiang, S.; Adams, A.C.; Sahin, E.; Kost-Alimova, M.; Protopopov, A.; Cadinanos, J.; et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469, 102-106.
11. de Jesus, B.B.; Schneeberger, K.; Vera, E.; Tejera, A.; Harley, C.B.; Blasco, M.A. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 2011, 10, 604-621.
12. Dagarag, M.; Evazyan, T.; Rao, N.; Effros, R.B., Genetic manipulation of telomerase in HIVspecific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J. Immunol. 2004, 173, 6303-6311.
13. Fauce, S.R.; Jamieson, B.D.; Chin, A.C.; Mitsuyasu, R.T.; Parish, S.T.; Ng, H.L.; Kitchen, C.M.; Yang, O.O.; Harley, C.B.; Effros, R.B. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J. Immunol. 2008, 181, 7400-7406.
14. Harley, C.B.; Liu, W.; Blasco, M.; Vera, E.; Andrews, W.H.; Briggs, L.A.; Raffaele, J.M. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res. 2011, 14, 45-56.
15. Harley, C.B.; Futcher, A.B.; Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345, 458-460.
16. Allsopp, R.C.; Vaziri, H.; Patterson, C.; Goldstein, S.; Younglai, E.V.; Futcher, A.B.; Greider, C.W.; Harley, C.B., Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 1992, 89, 10114-10118.
17. Bodnar, A.G.; Ouellette, M.; Frolkis, M.; Holt, S.E.; Chiu, C.P.; Morin, G.B.; Harley, C.B.; Shay, J.W.; Lichtsteiner, S.; Wright, W.E., Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279, 349-352.
18. Parish, S.T.; Wu, J.E.; Effros, R.B. Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J. Clin. Immunol. 2010, 30, 798-805.
19. Hooijberg, E.; Ruizendaal, J.J.; Snijders, P.J.; Kueter, E.W.; Walboomers, J.M.; Spits, H. Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J. Immunol. 2000, 165, 4239-4245.
20. Migliaccio, M.; Amacker, M.; Just, T.; Reichenbach, P.; Valmori, D.; Cerottini, J.C.; Romero, P.; Nabholz, M. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J. Immunol. 2000, 165, 4978-84.
21. Denzler, K.L.; Waters, R.; Jacobs, B.L.; Rochon, Y.; Langland, J.O. Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals. PLoS One 2010, 5, e12561.
22. Auyeung, K.K.; Mok, N.L.; Wong, C.M.; Cho, C.H.; Ko, J.K. Astragalus saponins modulate mTOR and ERK signaling to promote apoptosis through the extrinsic pathway in HT-29 colon cancer cells. Int. J. Mol. Med. 2010, 26, 341-9.
23. Collins, R.A. A ten-year audit of traditional Chinese medicine and other natural product research published in the Chinese Medical Journal (2000-2009). Chin. Med. J. (Engl) 2011, 124, 1401-1408.